Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2029 of 5804
-
New Stent-Suction combo shows promise for sealing gut leaks
Disease control CompletedThis registry is intended to collect data on quality assurance and use of the VAC-Stent® and thus verify the suitability of the VAC-Stent® for sealing leakages in the oesophagus or colon. Furthermore, the safety and efficacy of the VAC-Stent® shall be proven.
Sponsor: Markus M. Heiss • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Mesh showdown: which surgery fixes prolapse best?
Disease control Recruiting nowThe main objective of the study is to compare subjective efficacy of trans vaginal mesh and laparoscopic colposakropexy (CSP) in women with an apical prolapse. The CSP group is further divided into two sub-groups; one where the mesh fixation is only at the apical part of the vagi…
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Mystery heart attacks: new registry aims to solve MINOCA puzzle
Knowledge-focused Recruiting nowThe last 15 years the introduction of primary angioplasty has radically improved outcomes for acute myocardial infarction (AMI). However, the system wide availability of prompt investigation has revealed an important group of patients where progress has stalled, the diagnosis is …
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
New program aims to keep sepsis survivors out of the hospital
Disease control CompletedThe purpose of this study is to evaluate if implementation of the Sepsis Transition and Recovery (STAR) program within a large healthcare system will improve outcomes for high-risk patients with suspected sepsis, while concurrently examining contextual factors related to STAR pro…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 26, 2026 19:09 UTC
-
Mesh may stop hernias after big belly surgeries
Prevention Completedhe goal of this observational study is to learn about prophylactic mesh placement in HBP incision. The main question it aims to answer is: will the incisional hernia rate be reduced with the use of mesh during the abdominal wall closuer?
Phase: NA • Sponsor: Juan Bellido-Luque.MD • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Can aggressive meds shrink hidden plaque in women's arteries?
Knowledge-focused CompletedIn this study, quantitative characterization of plaque using coronary computed tomographic angiography (CTA) will be used to determine if women who were treated with intensive medical therapy have a greater reduction in the amount and type of cholesterol plaque compared to women …
Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Liver transplant patients get new hope: CertiroBell vs standard drug
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of CertiroBell® tablet compared with mycophenolate mofetil in primary living donor liver transplant recipients.
Phase: PHASE4 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Psilocybin depression study cut short: did the benefits last?
Symptom relief TerminatedThis is a Phase 2 double-blind, long-term observational follow-up study of participants from Study PSIL201. Participants providing informed consent were enrolled into this study and completed web surveys and telephone interviews conducted by one central site at the following time…
Sponsor: Usona Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Stem cell infusions aim to tame COVID-19 inflammation
Disease control TerminatedHope Biosciences is conducting a research study of an investigational product called allogeneic adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as treatment for patients suspected to have COVID-19. The study purpose is to evaluate the safety and efficacy of four…
Phase: PHASE2 • Sponsor: Hope Biosciences Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New embryo test could boost IVF success without poking the embryo
Diagnosis TerminatedChromosomal aneuploidies are linked with spontaneous miscarriages and abnormal offspring in human pregnancies. In addition, some types of aneuploidies are reported to prevent implantation. Thus, there is a need to identify the embryos with highest implantation potential on in vit…
Phase: NA • Sponsor: Igenomix • Aim: Diagnosis
Last updated Jun 27, 2026 07:52 UTC
-
New 6-in-1 shot for babies shows promise in thai trial
⭐️ VACCINE ⭐️ CompletedPrimary Objective: To demonstrate the non-inferiority of the SHAN6™ vaccine to the licensed SHAN5™ given with bOPV and IPV vaccines when coadministered with PCV and ORV Secondary Objective: * To describe the immunogenicity profile of the SHAN6™ vaccine 3-dose primary infant va…
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:51 UTC
-
Heart failure patients monitored in massive new registry
Disease control OngoingThe purpose of this registry is to develop valid scientific evidence of the safety and benefit of Barostim Therapy in the commercial setting in patients with heart failure with reduced ejection fraction (HFrEF) that were recently implanted with the Barostim System.
Sponsor: CVRx, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Experimental drug aims to prevent bleeding veins in fatty liver disease
Prevention TerminatedThis seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the efficacy, safety, and tolerability of belapectin compared with placebo in patients with nonalcoholic steatohepatitis (NASH) cirrhosis a…
Phase: PHASE2, PHASE3 • Sponsor: Galectin Therapeutics Inc. • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC
-
Cancer drug dosing study could cut clinic visits in half
Disease control Recruiting nowA randomized research study of drugs nivolumab and pembrolizumab in patients with locally advanced or metastatic cancers. Based on data from earlier studies it appears that the drugs can be given less often then the currently approved schedule. This trial will compare drug levels…
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
New drug combo tested for Hard-to-Treat cancers
Disease control OngoingThis first-time-in-human (FTIH) study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary clinical activity of escalating doses of GSK6097608 given as monotherapy and in combination with dostarlimab in participants with advanced s…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New study aims to map ovarian cancer in unprecedented detail
Knowledge-focused OngoingThe researchers are doing this study to find out whether the researchers can combine information provided by PET/MRI scans with information from tests on blood and tissue samples to develop a very detailed description (profile) of high-grade serous ovarian carcinoma (HGSOC), whic…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New hope for Hard-to-Treat prostate cancer? early trial underway
Disease control CompletedThe purpose of this study is to assess the safety, tolerability and preliminary efficacy of CC-94676 in men with progressive metastatic castration resistant prostate cancer.
Phase: PHASE1 • Sponsor: Celgene • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
One-Week radiation could ease pain for advanced cervical cancer patients
Symptom relief Recruiting nowThe present study is proposed to compare a rapid fractionation schedule of 1 week compared to a protracted schedule of 6-8 weeks for palliation for locally advanced cervical cancer.
Phase: NA • Sponsor: Tata Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Scientists probe why lung disease raises COVID-19 risk
Knowledge-focused CompletedDESIGN Longitudinal prospective observational multicentre study. Primary objective: Understand the immune mechanisms driving COVID-19 disease in patients with a history of lung disease
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Could a tiny electrical zap ease your back pain?
Symptom relief CompletedThe purpose of this study is to compare standard of care treatments for back pain to electrical stimulation. Stimulation is delivering small amounts of electricity to the nerves in your low back. This study will use a device called the SPRINT Peripheral Nerve Stimulation (PNS) Sy…
Phase: NA • Sponsor: SPR Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC